X4 Pharmaceuticals XFOR Q2 2026 earnings

FAQ

When did X4 Pharmaceuticals report Q2 2026 earnings?

X4 Pharmaceuticals (XFOR) reported Q2 2026 earnings on August 7, 2026 after market close.

What were X4 Pharmaceuticals's Q2 2026 revenue and EPS?

X4 Pharmaceuticals reported revenue of $8.8M and eps of $-0.13 for Q2 2026.

Did X4 Pharmaceuticals beat estimates in Q2 2026?

Revenue beat the consensus estimate of $2.4M by $6.4M. EPS beat the consensus estimate of $-0.18 by $0.05.

How did X4 Pharmaceuticals's Q2 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 346.3% from $2.0M a year earlier and eps grew 96.3% from $-3.47.

Where can I find X4 Pharmaceuticals's Q2 2026 SEC filings?

You can read the 10-Q periodic report (0001501697-26-000068) directly on SEC EDGAR. The filing index links above go to sec.gov.